Our easy-to-read fact sheet provides clinicians with an overview of the mechanism of GLP-1 agonists. Our easy-to-read fact sheets provide clinicians with reliable information to share with patients ...

Activating the glucagon-like peptide 1 receptor (GLP-1R) is the mechanism of action of most drugs currently used to treat obesity and type 2 diabetes. To enhance efficacy and reduce side effects, many ...

The question of putative mechanisms of action continues to haunt psychopharmacology. Put simply, we know these drugs work, but we have very little idea how. We make guesses based on the neurochemical ...

A new study has uncovered a critical role for the enzyme Glucose-6-phosphatase 2 (G6PC2) in regulating blood sugar levels. The research sheds new light on how this enzyme influences glucagon secretion ...